chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She received the vaccine on 08/15/2022. We waited about 15 minuets before leaving and as I was putting her in the car I felt her temperature rising. I gave her a TYLENOL when we got home. She took a nap and temperature went down a little.  After medicine wore off about 6 hours later her temperature raised again. Two days later she started constantly screaming and I took her to the doctor. The doctor checked her and found white small bumps in back of throat with an elevated temperature of 102.9. Daughter was then diagnosed with Coxsackie. Was told to continue giving her TYLENOL to ease pain. Symptoms still continuing however fever has subsided.
5 days after the vaccination, experienced facial paralysis affecting the right side, including eye, mouth cheek.  Those signs were preceded the night before with a sharp headache pain behind the right ear. Went to the hospital ER and diagnosed with Bell Palsey.   Treatment: valACYclovir HCI 1 gm tablet:  2 times a day for 7 days:  MethylTREDNISolone 4 mg tablets - doses titrated over 6 days.  As of today, symptoms are the same - have not changed
Neck & shoulder ache, headache, fever (100), shivering, tiredness. In addition to pain at injection site.
Very very tired; No energy; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Apr2021 at 16:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included lyme disease. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. Concomitant medications were not reported. On an unknown date in Apr2021, the patient was very very tired and had no energy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very very tired and no energy was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pneumovax injection given 6/23/04. Rash developed on same day, and worsened through 6/27/04. Patient developed swelling on 6/24/04. Patient developed nausea, vomiting, diarrhea on 6/24/04. Patient experienced shortness of breath on 6/25/04. Patient was admitted to hospital on 6/27/04 for intractable nausea and vomiting. Patient reports no other new medications started recently.  Nurse follow up on 09/16/04 states: "Review of d/c summary confirms previously coded symptoms. "
itchy; hand was really swollen from thumb to wrist; rash from the waist to under the breast and the sides; it felt like stings; my eyes kind of got a little bit hard to focus; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), PAIN (it felt like stings), DISTURBANCE IN ATTENTION (my eyes kind of got a little bit hard to focus), JOINT SWELLING (hand was really swollen from thumb to wrist) and RASH (rash from the waist to under the breast and the sides) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to allopathic drugs. Concomitant products included CLOPIDOGREL, EZETIMIBE, METOPROLOL and AMLODIPINE for an unknown indication.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PAIN (it felt like stings) and DISTURBANCE IN ATTENTION (my eyes kind of got a little bit hard to focus). On 09-Feb-2021, the patient experienced PRURITUS (itchy), JOINT SWELLING (hand was really swollen from thumb to wrist) and RASH (rash from the waist to under the breast and the sides). At the time of the report, PRURITUS (itchy), PAIN (it felt like stings), DISTURBANCE IN ATTENTION (my eyes kind of got a little bit hard to focus), JOINT SWELLING (hand was really swollen from thumb to wrist) and RASH (rash from the waist to under the breast and the sides) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided by Reporter.
sick to her stomach; shortness of breath; low grade fever of (normal body temp 99.7) temp is 99.4; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (shortness of breath) and PYREXIA (low grade fever of (normal body temp 99.7) temp is 99.4) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (shortness of breath) and PYREXIA (low grade fever of (normal body temp 99.7) temp is 99.4). At the time of the report, ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (shortness of breath) and PYREXIA (low grade fever of (normal body temp 99.7) temp is 99.4) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.7 (High) 99.7.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.   Reporter did not allow further contact
Started having sorenes at injection site in the pm of 18Oct04, then this am of 19Oct04 has localized swelling and redness, area is warm to the touch. Pt also states thet he has a general tingling sensation throughout his whole body.
Cellulitis of leg on 2013-06-22, clinician comment: Cellulitis was really on inner thigh under buttock and not at the site of vaccination.
Initial information received on 11-Jan-2019 regarding an unsolicited valid non-serious case received from a other health professional. In this case, the nurse did not mix up the HIB portion of the PENTACEL and injected of unknown batch no. via unknown route in unknown administration site. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was actual medication error due to inappropriate reconstitution technique. it was reported that the child patient was received half portion of PENTACEL. It was not reported that the patient had any adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
EE received COVID-19 vaccination at approximately 1730.  At 1745 she reported to this EHN that her neck is stiff and painful and she has tingling sensation in her left arm.  VSS: 140/84, p-60 rrr, R-14 non-labored.  EE was talking and walking without assistance.  She was sat in a chair, supported by a table on one side and the EHN on the other for assessment.  Skin WDI, no discolorations, skin color is WNL, capillary refill < 2 seconds.  No sx of respiratory distress.    1750, EE reports the tingling is worse and also in her neck.  VSS: 136/84, p-66 rrr, R-12 and non-labored.  EE reports a history of severe reaction to eggs and shellfish and flu shot w/ eggs but no reaction to Flublok without eggs.     EE was walked to the ER, escorted by 2 EHN with the Epi Kit.  EE arrived at the ER without incident and she was checked in.   She requested her manager be notified, ER staff called for her.
Elevated blood pressures.  No history of hypertension.  SBP 140-160 DBP 80-100.  Associated with headache, palpitations,  pulsatile whooshing in the ears
my arm was less sore after I received the 2nd shot than it was for my first shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 24 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Apr2021 09:00 (Lot number: EW0162) at the age of 24 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: CONCERTA; IBUPROFEN. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovered", described as "my arm was less sore after I received the 2nd shot than it was for my first shot". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: Patient arm was less sore after received the 2nd shot than it was for first shot. She did not have known allergies. Patient did not receive other vaccine in four weeks of vaccination. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination.  No follow-up attempts are possible. No further information is expected.
Information has been received from a medical assistance referring to an unknown age and gender patient. No information was provided regarding the patient's medical history, current conditions or drug reactions or allergies. On 15-MAR-2019, the patient was vaccinated with an expired dose of with ROTATEQ orally for prophylaxis, with lot number N021308 and expiration date on 05-MAR-2019 (strength, dose, dose number, route of administration and anatomical injection site were not reported). No adverse effects were reported in the patient.
The pt was given the vaccines on 3/22/00. Mom reports that the infant began a fever that night which went up to 103 degrees. The fever subsided the next day (3/23/00). On 3/25/00, the child broke out in a measles type rash. Mom called the pediatrician and the clinic to report the reaction.
The pt felt a sharp pain to the left shoulder and arm at the time of injection. Moderate edema and redness at the injection site for 1 hour. No improvement after 3 days. The pt was seen by MD. Treated with Motrin and warm packs.
Passed out immediately after HPV shot.  Had stinging on right side above pelvic bone for a couple of days after.  Had full body muscle soreness for a couple of days after.  Had dizziness during first menstruation after.
Shoulder injury. noted red and raised, hot to touch. Painful when touched.  Staff was evaluated by the attending emergency department MD and was provided with a steroid to take by mouth.  Approximately at 5:00PM, employee health nurse looked at left upper arm and the swelling had decreased very little. Still red and warm to touch.
Hives x 24 hrs. that developed 5 days after shots given. Tactile fever 5 days after shots (for 1 day).
Received Moderna 1st dose on 12/29/2020.  Was in the hospital on 1/17/21-1/21/21 for severe hypotension and removal and replacement of hemodialysis shunt.
SWELLING IN LYMPH NODES IN MID TO LATE JUNE.  SEVERE SWELLING LASTING THROUGH AUGUST.   SWELLING STILL BUT NOT AS MUCH AT TIME OF REPORTING
Large, silver dollar sized area of swelling and redness.; redness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 47-years-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right (Lot number: FJ8762) as DOSE 1, SINGLE for covid-19 immunization. Relevant medical history included: "CIU" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Compazine, reaction(s): "known allergies: Compazine", notes: known allergies: Compazine; Cephalosporins, reaction(s): "known allergies: Cephalosporins", notes: known allergies: Cephalosporins; Clindamycin, reaction(s): "known allergies: Clindamycin", notes: known allergies: Clindamycin. The following information was reported: SWELLING (non-serious) with onset 20Dec2021, outcome "not recovered", described as "Large, silver coin piece sized area of swelling and redness."; ERYTHEMA (non-serious) with onset 20Dec2021, outcome "not recovered", described as "redness". The events "large, silver coin piece sized area of swelling and redness." and "redness" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of swelling, erythema.  Additional Information: The patient had known allergies: Compazine, Cephalosporins, Clindamycin. Other medical history: CIU. The patient had no other vaccines within 4 weeks. She did not have COVID-19 prior to vaccination and was not tested for COVID-19 post the vaccination.  No follow-up attempts are possible. No further information is expected. .
Returned to clinic on 2/7/01 with redness and swelling in upper left arm. Also had swollen upper lip that AM but this resolved.
Information has been received from a registered nurse concerning a 9 year old male who on 13-JUL-1999 was vaccinated with a dose of Varivax. On 05-MAY-2006 the patient developed a breakthrough case of varicella. It was reported that the patient had less than 50 lesions on his trunk. The patient received no treatment and he was not hospitalized. No further information was available. There was no product quality complaint involved. Additional information has been requested. The patient's siblings (WAES # 0608USA06083 and 0608USA06085) had similar experiences following vaccination with Varivax.
Patient returned to pharmacy 48 hours after receiving pneumonia vaccine with red area around injection site. Redness and soreness was visible for 6 inches around the site. Patient took BENADRYL 50 mg for 4 doses and reported the issue resolved without any further treatment no reaction on left arm.
This case was reported by a consumer via call center representative and described the occurrence of fever in a 64-year-old male patient who received SHINGRIX for prophylaxis. On 28th December 2018, the patient received the 1st dose of SHINGRIX. On 30th December 2018, 2 days after receiving SHINGRIX, the patient experienced fever, swelling arm and muscle pain. On 31st December 2018, the patient experienced sores mouth and fever blister. On an unknown date, the outcome of the fever, swelling arm, muscle pain, sores mouth and fever blister were recovered/resolved. It was unknown if the reporter considered the fever, swelling arm, muscle pain, sores mouth and fever blister to be related to SHINGRIX. Additional detail were provided as follows: The patient had fever, arm swelling, muscle aches after a couple days and mouth sores and fever blister about 3 days after. For tolerance to 2nd dose, refer case US2019GSK044633.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. Medical history was not reported. The nurse informed that on 14-MAY-2014 the patient was vaccinated with M-M-R II (strength, dosage and route were not reported) lot number: J006955, expiration date: 07-JUN-2015. That may had been improperly stored since February 2014. The thermometer battery ran out in February 2014, so the refrigerator temperature was not able to be confirmed was not able to be confirmed to be within recommended storage temperature since then. The highest temperature the M-M-R II could had been exposed was 70F. Also stated that was no way to determine what the exact temperature was at any given time after 01-FEB-2014 since the battery in the thermometer stopped working. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was administered with a dose of Moderna from a vial that had been punctured for more than 12 hours) and PRODUCT STORAGE ERROR (patient was administered  with a dose of Moderna from a vial that had been punctured for more than 12 hours) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was administered with a dose of Moderna from a vial that had been punctured for more than 12 hours). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (patient was administered  with a dose of Moderna from a vial that had been punctured for more than 12 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was administered  with a dose of Moderna from a vial that had been punctured for more than 12 hours) and PRODUCT STORAGE ERROR (patient was administered  with a dose of Moderna from a vial that had been punctured for more than 12 hours) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that patient was administered with second booster dose. It was reported that Number of doses/vials administered were 3 doses. The vial was initially stored in the refrigerator on 15-Apr-2022. The vial was first punctured at 11:50AM on 19-Apr-2022. The vial was stored at room temperature post puncture. It was reported that the vial was left on countertop overnight. Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F) was 24 hours. No concomitant medications were reported. No treatment medications were reported. This case was linked to MOD-2022-546072, MOD-2022-546074 (Patient Link).
Prolonged sore shoulder for at least 23 hours where the vaccine was injected; stye in right eye lid (I don't think it's related though); This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EJ3247; Expiration date was not reported), via an unspecified route of administration on 09Mar2021 10:00 (at the age of 34-years-old) as first dose, single dose for COVID-19 immunisation at a workplace clinic. Medical history included bowel obstruction removal in 2011; and thyroid nodule, cephalosporin allergy which caused itch both from an unknown date and unknown if ongoing. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. Concomitant medications included vitamin B complex and folic acid (FOLATE); both taken for an unspecified indication, start and stop dates were not reported. On 09Mar2021 10:00 AM, the patient experienced prolonged sore shoulder for at least 23 hours where the vaccine was injected and stye in right eye lid. The patient thought that the stye was not related to the vaccine. No treatment was taken for the event. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected
Sudden onset of chest tightness with shortness of breath 20 minutes  after receiving the vaccine. Symptoms last for 10 minutes
Day one of vaccine approximately 6 hours after vaccination I experienced fatigue, rapid heartbeat and minor headaches.  I then took 2 Aleve to relieve symptoms.  Day 3 after vaccination I experienced soreness at the injection site. I did not take any pain meds for the soreness. On day 8(today) after vaccination I?m experiencing swelling and itching at injection site. My skin is also warm to the touch at the injection site. If symptoms continue I will take Benadryl to try to relieve the itching.
A patient was administered an expired dose of the Moderna COVID-19 vaccine.  Vaccine expiration date was 9/13/2021.
Initial reaction was headache and nausea. By 2/25 not 24 hours later, I experienced explosive diarrhea. This continued consistently for 9 weeks. During this time I lost 30 lbs. My bowels are not the same and it is 7 months later.
area was itchy; rash around his injection site; area was red; area was tender; area was swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (area was itchy), VACCINATION SITE RASH (rash around his injection site), VACCINATION SITE ERYTHEMA (area was red), VACCINATION SITE PAIN (area was tender) and VACCINATION SITE SWELLING (area was swollen) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (area was itchy), VACCINATION SITE RASH (rash around his injection site), VACCINATION SITE ERYTHEMA (area was red), VACCINATION SITE PAIN (area was tender) and VACCINATION SITE SWELLING (area was swollen). At the time of the report, VACCINATION SITE PRURITUS (area was itchy), VACCINATION SITE RASH (rash around his injection site), VACCINATION SITE ERYTHEMA (area was red), VACCINATION SITE PAIN (area was tender) and VACCINATION SITE SWELLING (area was swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication were provided. no concomitant were provided.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow up received on 06-May-2021, no new information was recorded
Pt developed headache the next afternoon after receiving the Tdap vaccination.  By that evening, pt had fever of 100.6 degrees and then went up to 103 degrees.  Pt experienced shooting pain going down to her fingertips in the arm that received the injection.  Pt also experienced much fatigue.
5 minutes after administration of vaccine, Patient had visual white-out of vision, diminished hearing, disoriented, severe pallor and then vomitted.
Information has been received from a nurse referring to a 20 year old patient of unknown gender. The patient's pertinent medical history and drug reactions/allergies were not reported. On 11-AUG-2015, the patient was vaccinated with ZOSTAVAX (lot # L006381, expiration date 25-MAY-2016) (route and dose were not provided) instead of VARIVAX (wrong vaccine administered). No adverse events were reported. Additional information has been requested.